CANCER IMMUNOTHERAPY INDEX

The Loncar Cancer Immunotherapy Index seeks to track the combined performance of a basket of companies that develop therapies to treat cancer by harnessing the body's own immune system. Immunotherapy is a transformational field within the biotechnology space that is expected to become a foundational treatment for cancer over the next ten years.  The index will provide a metric to follow its progress as researchers advance new technologies for the benefit of courageous patients who fight the disease.  It is an equal-weighted index containing both large pharmaceutical and growth-oriented biotechnology companies that are leading in this approach.

Screen Shot 2022-05-16 at 4.10.08 PM.png
Screen Shot 2022-05-16 at 11.02.09 PM.png
Screen Shot 2022-05-16 at 11.02.48 PM.png

Chart

Index Constituents

Click on a name to learn more about its immunotherapy program

Screen Shot 2022-05-16 at 4.10.57 PM.png

Prices delayed up to 15 min

regeneron-regn-logo.png
logo-49.png
image2-2.jpg
rHqnvszj_400x400.png
KR6D6PeA.jpeg
vM5vzXvw.png
0mrFDT2w.jpeg
nuWloqwg.jpeg
yPcL9Gyw.png
IMAB-Logo.png
NASDAQ_ATRA.png
logo-ALX-Oncology-Apr18_color.jpg
Genmab.jpg
Rubius_Logo.jpg
InstilBio.png
ImmunityBio.png
712_main.jpg
Full_Caribou_Logo_Dual_R.jpg
Immunocore.jpg
inhibrx_Logo.jpg
iTeos.jpg

Loncar Investments, LLC : P.O Box 15072, Lenexa, KS  66285 : 913-871-5007 : Not investment advice or a solicitation to buy or sell securities